🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The community is growing!!

Spanish research on controlled drug delivery is strongly represented at #CRS2024 by an impressive lineup of experts including CIPF @MariaJ_Alonso, iMATUS (Instituto de Materiales de la USC) @I+DFarmaUSC CSIC Divulga UPV/EHU USC Universidad de Sevilla, Universidad complutense de madrid CiMUS, Alvaro Somoza, and more!

Great time presenting our poster at the Controlled Release Society meeting. Poster 1207!!! ,, too much science packed in a hall

Yes!.. great honor. Many thanks!

Great work! Congrats !

Wonderful talk by Olivia Merkel during the Gene Delivery Gene Editing session of the Controlled Release Society meeting . CRS Focus Group - Gene Delivery and Gene Editing @LabMerkel

Some members of the CRS Focus Group - Gene Delivery and Gene Editing have gathered during the Controlled Release Society meeting in Bolonia. Excellent place to enjoy good food and science. Ioanna Mylonaki

RANN XIII meeting is taking place this week. Everything is almost ready to go. Have all a good and safe trip to Alcalá! See you on Thurs, many thanks for your interest. rann2024.org Universidad Alcalá IQAR-UAH IDISCAM #ChemGenes RSEQ-STMadrid Grupo QBio RSEQ IS3NA #Scharlab

Great meme ting in Alcalá De Henares. Thanks to ⁦Lourdes Gude⁩ @rann2024.org and all people make this possible. Universidad Alcalá IQAR-UAH IDISCAM #ChemGenes RSEQ-STMadrid Grupo QBio RSEQ IS3NA

Excellent meeting on nucleic acids rann2024.org at Universidad Alcalá , where we have discussed a wide variety of topics, including novel therapeutics, non-canonical structures, and sustainable production of oligonucleotides Masad J. Damha #RANN13 Grupo QBio RSEQ, Lourdes Gude

Big thanks to Lourdes Gude and the rest of the organizing committee of rann2024.org for another edition of the RANN conference (Alcalá, Spain) in which I was privileged to attend and participate and meet so many of my wonderful colleagues in Spain and abroad. Carlos Gonzalez

A pleasure hosting the RANN XIII meeting. We enjoyed great science and the company of RANN friends. Many thanks for participating and collaborating to make it possible. Hope to see you all in 2026 😉 Universidad Alcalá Fundación General de la Universidad de Alcalá IQAR-UAH IDISCAM #ChemGenes Grupo QBio RSEQ RSEQ-STMadrid IS3NA

🧬 Gene Delivery and Gene Editing Young Researchers Symposium - Call for Abstracts! 🧬 📢 Join us on 25th Feb at 16h CET for an exciting event showcasing the latest gene delivery and editing research and spotlighting young scientists in 3-minute talks! More information below ⬇️

🗓️ Submission Deadline: 15th January 📜 Abstract Format: 300 words max, including title, authors, and a brief summary of your research 📩 Submit your abstract to: [email protected]

En 2025, #NanoMedSpain y ETP Nanomedicine celebramos el 20 aniversario de las plataformas española y europea de Nanomedicina. 📅Únete a #NME25, del 27 al 30 de mayo en Barcelona. ⏳#EarlyBird ampliado hasta 19 de enero. Inscríbete y envía tu abstract: nme25.eu

Our publication of the project from Alvaro Somoza, Daniela Palacios and Jean-Jacques Toulmé labs is already available! Don't miss it if you are interested in targeting muscle stem cells with aptamer-good nanoparticles! IMDEA Nanociencia 🔬 CNR Consiglio Nazionale delle Ricerche Nature Communications nature.com/articles/s4146…

Researchers hit the target: they transport #microRNAs against #MuscularDystrophy to muscle stem cells using nanoparticles. 🎯 Treated mice showed improved muscle strength. +info: nanociencia.imdea.org/home-en/news/i… #IMDEAnanoPublications Alvaro Somoza Nature Communications #MusclesMatter #duchenne

It has been a great adventure! Thanks Mariola Tortosa for counting with us. Congrats to all!. Very well deserved!

Álvaro Somoza Alvaro Somoza IMDEA Nanociencia 🔬 participa con la charla "Ácidos nucleicos y Nanomedicina: nuevas estrategias para tratar la distrofia muscular de Duchenne". #RareDiseaseDay

Ha sido una jornada increíble. Enhorabuena!. Hoy hemos visto excelentes ejemplos de terapias para el tratamiento de las enfermedades minoritarias. Nosotros exploramos el uso de nanoparticulas de oro y miRNAs para tratar la distrofia muscular de Duchenne. IMDEA Nanociencia 🔬